SE7709071L - Olivansyraestrar - Google Patents

Olivansyraestrar

Info

Publication number
SE7709071L
SE7709071L SE7709071A SE7709071A SE7709071L SE 7709071 L SE7709071 L SE 7709071L SE 7709071 A SE7709071 A SE 7709071A SE 7709071 A SE7709071 A SE 7709071A SE 7709071 L SE7709071 L SE 7709071L
Authority
SE
Sweden
Prior art keywords
acid esters
olivanic acid
gram
olivanic
penicillins
Prior art date
Application number
SE7709071A
Other languages
English (en)
Swedish (sv)
Other versions
SE7709071A0 (sv
Inventor
D F Corbett
A J Eglington
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7709071A0 publication Critical patent/SE7709071A0/sv
Publication of SE7709071L publication Critical patent/SE7709071L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7709071A 1976-08-17 1977-08-10 Olivansyraestrar SE7709071L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34106/76A GB1531141A (en) 1976-08-17 1976-08-17 Beta-lactam antibiotics

Publications (2)

Publication Number Publication Date
SE7709071A0 SE7709071A0 (sv) 1978-02-17
SE7709071L true SE7709071L (sv) 1978-02-17

Family

ID=10361448

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709071A SE7709071L (sv) 1976-08-17 1977-08-10 Olivansyraestrar

Country Status (19)

Country Link
JP (1) JPS5323995A (fi)
AT (1) AT351678B (fi)
AU (1) AU518375B2 (fi)
BE (1) BE857781A (fi)
CA (1) CA1104139A (fi)
CH (1) CH639664A5 (fi)
DE (1) DE2736482A1 (fi)
DK (1) DK364177A (fi)
ES (1) ES461691A1 (fi)
FI (1) FI772432A (fi)
FR (2) FR2362142A1 (fi)
GB (1) GB1531141A (fi)
IE (1) IE45559B1 (fi)
IL (1) IL52638A (fi)
NL (1) NL7709007A (fi)
NZ (1) NZ184808A (fi)
PT (1) PT66882B (fi)
SE (1) SE7709071L (fi)
ZA (1) ZA774703B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
EP0004132A1 (en) * 1978-03-04 1979-09-19 Beecham Group Plc Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
DE2963580D1 (en) * 1978-08-02 1982-10-21 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
DE3070269D1 (en) * 1979-08-10 1985-04-18 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
EP0044142A1 (en) * 1980-07-03 1982-01-20 Beecham Group Plc Process for the preparation of beta-lactam antibiotics
EP0057565A1 (en) * 1981-02-04 1982-08-11 Beecham Group Plc Beta-lactam antibiotics, their preparation and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Also Published As

Publication number Publication date
JPS5323995A (en) 1978-03-06
FR2405260B1 (fi) 1980-10-31
CH639664A5 (en) 1983-11-30
FI772432A (fi) 1978-02-18
CA1104139A (en) 1981-06-30
AT351678B (de) 1979-08-10
BE857781A (fr) 1978-02-13
DK364177A (da) 1978-02-18
AU518375B2 (en) 1981-10-01
DE2736482A1 (de) 1978-02-23
ES461691A1 (es) 1978-06-01
FR2362142B1 (fi) 1981-11-06
PT66882B (fr) 1979-01-24
PT66882A (fr) 1977-09-01
GB1531141A (en) 1978-11-01
SE7709071A0 (sv) 1978-02-17
IE45559L (en) 1978-02-17
NL7709007A (nl) 1978-02-21
IE45559B1 (en) 1982-09-22
FR2405260A1 (fr) 1979-05-04
AU2798677A (en) 1979-02-22
ZA774703B (en) 1978-06-28
IL52638A0 (en) 1977-10-31
IL52638A (en) 1980-12-31
FR2362142A1 (fr) 1978-03-17
ATA592177A (de) 1979-01-15
NZ184808A (en) 1980-04-28

Similar Documents

Publication Publication Date Title
SE8305916L (sv) Mellanprodukter for framstellning av penicillansyra-1,1-dioxider
ES470437A1 (es) Un procedimiento para la preparacion de nuevos esteres an- tibacterianos
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
IE782546L (en) Amino-thiazolyl cephalosporins
SE7709071L (sv) Olivansyraestrar
SE7706081L (sv) Forfarande for framstellning av cefalosporiner
ES455404A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
FR2191556A5 (en) N-Acylampicillins - with broad-spectrum antibacterial activity prepd. by acylation with naphthyridine carboxylic acids
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
IE38615L (en) Penicillin compounds
GB1547473A (en) Cephalosporin compounds
ES442217A1 (es) Procedimiento para la obtencion de derivados cefem.
SE7600397L (sv) Forfarande for framstellning av penicilliner
FI54495B (fi) Foerfarande foer framstaellning av ett gentemot gram-positiva bakterier aktivt polypeptid-antibiotikum benaemnd gardimycin
SE7712645L (sv) Monocykliska beta-laktamer med antibakteriell aktivitet
ES438853A1 (es) Un procedimiento de preparacion de nuevos esteres de acidos cefalosporinicos.
SE8008540L (sv) N-substituerade tiazolylderivat av oxi-imino-substituerade cefalosporiner och forfarande for framstellning derav
SE7713710L (sv) Framstellning av nya etrar
FR2361403A1 (fr) 7-12-(2-imino-3-hydroxy-4-thiazolin-4-ml)-acetamido) antibiotiques
SE8303727L (sv) Cefalosporinantibiotika
GB1539053A (en) Process for the preparation of alpha-(2-oxoimidazolidinyl carbonylamino)-acetamido cephalosporins
IE42666L (en) Deoxyclavulanic acid and deoxyisoclavulanic acid and¹derivatives thereof
GB2013198A (en) Preparation of the pivaloyloxymethyl ester of Cephalexin
GB1421526A (en) Penicillins and cephalosporins
ES454009A1 (es) Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7709071-0